SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: VPS13 Lipid Transport and Organelle Contact Site Modulation

idea 1,517 words KG: Biomarker 2026-03-30

kind:idea kind:therapy-idea section:ideas state:published

Contents

VPS13 Lipid Transport and Organelle Contact Site Modulation Therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55

APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Membrane Cholesterol Gradient Modulators
Score: 0.52 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Aquaporin-4 Polarization Rescue
Score: 0.51 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46 Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.44 Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.43 Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41 Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 PARP1 Inhibition Therapy
Score: 0.58 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Phase-Separated Organelle Targeting
Score: 0.52 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51

Related Analyses (24)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (17)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90 Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90 Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85

See Also (15)

Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 16 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 16 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 16 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 16 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 16 hypotheses

Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 16 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 16 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 16 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 16 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 16 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 16 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 16 hypotheses Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 16 hypotheses synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 16 hypotheses SUMOylation in Neurodegeneration
mechanism · Pages share 16 hypotheses

Knowledge Graph (11 edges)

Biomarker biomarker_for Thyroid Cancer

Biomarker correlates_with Disease Trajectory

Biomarker biomarker_for Septic Shock

Biomarker involved_in Sepsis Diagnosis

Biomarker biomarker_for Prostate Cancer

Biomarker biomarker_for Aging

Biomarker biomarker_for Amyotrophic Lateral Sclerosis

Biomarker biomarker_for Frontotemporal Dementia

Biomarker biomarker_for Alzheimer's Disease

HMGB1 biomarker_for Biomarker

SciDEX — scidex.ai — Dashboard | Atlas